Results 161 to 170 of about 43,370 (248)

Parvovirus B19-associated fat embolism syndrome in sickle cell disease: A report of two cases. [PDF]

Clin Med (Lond)
Corby A, Lubel J, Stuart-Smith S, de Kreuk A, Kesse-Adu R, Lampejo T.   +5 more
europepmc   +1 more source

Analytical and Clinical Performance of the Atellica HEMA 580 Haematology Analyzer: A Comparison With the ADVIA 2120i

International Journal of Laboratory Hematology, Volume 48, Issue 4, Page 784-794, August 2026.
ABSTRACT Introduction The Atellica HEMA 580 is a novel haematology analyser providing eight‐part leukocyte differential and optical platelet (PLT) counting. We compared its analytical and clinical performance with that of the ADVIA 2120i. Methods A total of 796 residual whole blood specimens were analysed.
Hyeongyu Lee, Jooyoung Cho, Gilsung Yoo, Juwon Kim   +3 more
wiley   +1 more source

Transfusion-related immunomodulation effect of erythrocyte characteristics on immune cells traits based on a multivariable Mendelian randomization study. [PDF]

Int J Surg
Wang Y, Wang J, Wang H, Cheng Z, You L, Hu BJ, Li H, Wu J, Wang L, Ju Y, Guo J.   +10 more
europepmc   +1 more source

Perennial Parameter for Intravenous Iron Therapy in Heart Failure: Reticulocyte Crisis. [PDF]

Anatol J Cardiol
Kumral Z, Uysal H, Yılmaz MB.
europepmc   +1 more source

Safety and tolerability of amustaline/glutathione pathogen‐reduced red blood cells in neonatal rats

Transfusion, Volume 66, Issue 8, Page 1603-1612, August 2026.
Abstract Background Amustaline (S‐303)/glutathione (GSH) pathogen‐reduced red blood cells (PR‐RBCs) are in development for all adult and pediatric RBC transfusion indications, including neonates and infants. A neonatal rat model evaluated the safety and tolerability of PR‐RBCs during growth and maturation. Study Design and Methods Repeated transfusions
Anne North, Laurence Corash, Richard J. Benjamin, Nina Mufti   +3 more
wiley   +1 more source

Monoclonal Gammopathy as a Potential Cause of Pure Red Cell Aplasia: A Case Report and Literature Review. [PDF]

Cureus
De Weerdt P, Van Riet I, Fostier K.
europepmc   +1 more source

Intermittent exogenous ketosis increases erythropoietin in healthy adults: A randomized, placebo‐controlled study with preliminary sex‐specific observations

Physiological Reports, Volume 14, Issue 15, August 2026.
Intermittent exogenous ketosis stimulates erythropoietin, with greater EPO response and elevated ferritin in females but no significant changes in circulating hemoglobin or red blood cell count at 2 weeks. Abstract Exogenous ketosis may stimulate erythropoietin (EPO), yet its impact on erythropoiesis, iron metabolism, and potential sex‐specific ...
Henrik Holm Thomsen, Birgitte Sandfeld‐Paulsen, Lise Nørkjær Bjerg, Jesper Nørgaard Bech   +3 more
wiley   +1 more source

Delayed Autoimmune Hemolytic Anemia After Remission in Non-Hodgkin Lymphoma. [PDF]

Cureus
Azinge N, Bishaw T, Veluri R, Bisrat M, Deonarine A, Ali A.   +5 more
europepmc   +1 more source

Safety and efficacy of a feed additive consisting of nicarbazin (NICACOX®) for chickens for fattening and chickens reared for laying (Huvepharma N.V.)

EFSA Journal, Volume 24, Issue 8, August 2026.
Abstract Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of a feed additive consisting of nicarbazin (NICACOX®) as a coccidiostat for chickens for fattening and chickens reared for laying.
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Roberto Edoardo Villa, Giovanna Azimonti, Eleftherios Bonos, Henrik Christensen, Mojca Durjava, Birgit Dusemund, Ronette Gehring, Boet Glandorf, Maryline Kouba, Marta López‐Alonso, Francesca Marcon, Giovanna Martelli, Carlo Nebbia, Alena Pechová, Miguel Prieto‐Maradona, Katerina Theodoridou, Georges Bories, Paul Brantom, Jürgen Gropp, Guido Rychen, Luca Tosti, Ruud Woutersen, Jaume Galobart, Fabiola Pizzo, Alberto Navarro‐Villa, Maria Vittoria Vettori, José Cortiñas Abrahantes, Orsolya Holczknecht   +28 more
wiley   +1 more source

Extreme Hyperhemolysis Syndrome in a Patient With Sickle Cell Disease Successfully Managed With Eculizumab: A Case of Survival at 1.2 g/dL Hemoglobin. [PDF]

Cureus
Cordeiro I, Cerca C, Pinheiro M, Pratas C, Germano N.   +4 more
europepmc   +1 more source